(Q48300202)

10 February 2018

title

Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials (English)

1 reference

10 February 2018

main subject

Clostridium difficile

0 references

1 reference

1 reference

3

Dale N Gerding

1 reference

10 February 2018

4

Oliver A Cornely

1 reference

10 February 2018

author name string

Stuart Johnson

1

1 reference

10 February 2018

Thomas J Louie

2

1 reference

10 February 2018

Scott Chasan-Taber

5

1 reference

10 February 2018

David Fitts

6

1 reference

10 February 2018

Steven P Gelone

7

1 reference

10 February 2018

Colin Broom

8

1 reference

10 February 2018

David M Davidson

9

1 reference

10 February 2018

Polymer Alternative for CDI Treatment (PACT) investigators

10

1 reference

10 February 2018

language of work or name

English

0 references

publication date

5 May 2014

1 reference

10 February 2018

Clinical Infectious Diseases

published in

1 reference

10 February 2018

volume

59

1 reference

10 February 2018

issue

3

1 reference

10 February 2018

page(s)

345-354

1 reference

10 February 2018

Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU313

Increase in Clostridium difficile-related mortality rates, United States, 1999-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU313

Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU313

Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU313

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU313

Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU313

A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU313

OPT-80 eliminates Clostridium difficile and is sparing of bacteroides species during treatment of C. difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU313

Tolevamer, an anionic polymer, neutralizes toxins produced by the BI/027 strains of Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU313

Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU313

Factors associated with failure of metronidazole in Clostridium difficile-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU313

Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU313

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU313

Fidaxomicin versus vancomycin for Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU313

Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU313

An epidemic, toxin gene-variant strain of Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU313

Clostridium difficile outbreak strain BI is highly endemic in Chicago area hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU313

Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU313

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU313

Clostridium difficile infection in Europe: a hospital-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU313

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU313

21 January 2018

Identifiers

DOI

10.1093/CID/CIU313

1 reference

10 February 2018

1 reference

10 February 2018